NAGE

Niagen Bioscience Stock Analysis

AI Rating

Great
  • Quality8/10
  • Growth↑ 9/10
  • Value↑ 5/10
Niagen Bioscience sales and earnings growth
NAGE Growth
Great
  • Revenue Y/Y↑ 17.32%
  • EPS Y/Y↑ 33.33%
  • FCF Y/Y↓ -79.01%
Niagen Bioscience gross and profit margin trends
NAGE Profitability
Great
  • Gross margin ↑ 64.30%
  • EPS margin↑ 14.30%
  • ROIC 5Y↑ 63.01%
Niagen Bioscience net debt vs free cash flow
NAGE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Niagen Bioscience stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks